Meng, Qinghua et al. published their patent in 2022 |CAS: 1255717-13-5

The Article related to heterocyclic glp1 agonist preparation treatment disease, Heterocyclic Compounds (More Than One Hetero Atom): Other 5-Membered Rings, Two Or More Hetero Atoms and other aspects.Computed Properties of 1255717-13-5

On February 10, 2022, Meng, Qinghua; Lei, Hui; Zhang, Haizhen; Lin, Xichen; Jennings, Andrew published a patent.Computed Properties of 1255717-13-5 The title of the patent was Heterocyclic GLP-1 agonists. And the patent contained the following:

This disclosure relates to GLP-1 agonists of Formula I, including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same. The experimental process involved the reaction of (1-Ethyl-1H-imidazol-5-yl)methanamine dihydrochloride(cas: 1255717-13-5).Computed Properties of 1255717-13-5

The Article related to heterocyclic glp1 agonist preparation treatment disease, Heterocyclic Compounds (More Than One Hetero Atom): Other 5-Membered Rings, Two Or More Hetero Atoms and other aspects.Computed Properties of 1255717-13-5

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem